Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Cardamom has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Cardamom and cinnamon have each been trialled separately on glycaemic markers in adults with raised fasting glucose, with modest and inconsistent results in both cases. Combining them is plausible on mechanism and is standard in culinary practice. No trial has tested the pair against either spice alone, so the additive case is inference.
Ginger and cardamom appear together in masala blends and in traditional digestive preparations across South Asia and the Middle East. Both have been examined for effects on circulating inflammatory markers. The pairing rests on tradition and marker-level overlap rather than a head-to-head trial.
Cardamom work has reported changes in oxidative stress and inflammatory markers in adults with elevated blood lipids, and curcumin has a much larger literature on the same marker set. A marker is not an outcome, and neither ingredient has been shown to add to the other in a controlled comparison.
Berberine has a substantial literature on lowering fasting glucose, and cardamom's own glycaemic signal is smaller and less consistent. Stacked in the same regimen the glucose-lowering directions point the same way, which matters most for anyone already on glucose-lowering medication. This is a caution to raise with a prescriber, not a recommended combination.
1,8-cineole, alpha-terpinyl acetate and limonene partition into lipid rather than water. A lipid carrier keeps them in solution through the small intestine and is the standard vehicle for essential oil softgels. This affects delivery, not potency.
Cardamom appears in traditional after-meal preparations across South Asia, which is why it turns up in modern digestive blends next to enzyme preparations. The pairing is formulation convention. The traditional use is documented; a controlled test of the combination is not.
Nothing specific on file for Cardamom. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 9 we read for Cardamom. The full linked list is below.
4 sources behind our Cardamom verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 104 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Cardamom is, not how risky it is. A report is not proof Cardamom caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.